AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2018
Apr 19, 2018
34105_dirs_2018-04-19_57cf2b94-108b-48c2-b277-28b2d56b12d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2018-04-18
Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-04-18 | Common Stock (Right to Buy) | $9.8514 | A | 40000 | Acquired | 2025-04-18 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock; $.10 par value | 270288 | Direct |
Footnotes
F1: These options vest as follows: 13,334 shares on 4-18-2019; 13,333 shares vest on 4-18-2020 and 13,333 shares vest on 4-18-2021.
More from ULTRALIFE CORP
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 16